Global Biophotonics Market – Industry Trends, Opportunities and Forecasts to 2023
Global Biophotonics Market is projected to grow to US$72.267 billion by 2023, from US$46.036 billion in 2018 growing at a CAGR of 9.44% over the forecast period. Demand for the quality healthcare, growing prevalence of personalized medication and development of healthcare instruments with a photonic component for higher accuracy and sensitivity are some of the key factors for the growth of biophotonics in the global healthcare sector. Government and private funding for research and development activities and the emergence of non-medical applications such as prevention of unauthorized access to confidential data and pathogen detection in agriculture products further propel the growth of global biophotonics market. Growing need for biophotonics systems for the detection of biochemical agents used in warfare and terror attacks will augment the demand for biophotonics by defense sector in the coming years. Since biophotonics systems are also used in environmental monitoring, rising environmental issues such as pollution and global warming will further drive the market growth.
Endoscopic applications of Biophotonics instruments help in minimal or non-invasive surgical treatment and hold the largest market share due to early adoption. Use of biophotonics for early diagnosis of the diseases such as cancer and others has also helped to capture major market globally. North America region is the largest in terms of market share while the Asia Pacific is expected to grow at the fastest rate during the next five years. This is due to growing cases of chronic diseases coupled with rising aging as well as the geriatric population in the region. However, the growth of global biophotonics market will be restrained due to highly complex biophotonics technology coupled with the high price of biophotonics-based instruments during the forecast period.
Research Methodology
The report provides brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.
Market Dynamics
This section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of biophotonics. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.
Segmentation
Global biophotonics market is segmented on the basis of end-user, application, technology, and geography.
By End User
Medical
Diagnostics
Therapeutics
Test Component
Non-Medical
By Application
See-through
Inside Imaging
Surface Imaging
Microscopy
Light Therapy
Biosensor
Others
By Technology
In-Vivo
In-Vitro
By Geography
North America
US
Canada
Mexico
Others
South America
Brazil
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Asia Pacific
Japan
China
India
Australia
Others
Endoscopic applications of Biophotonics instruments help in minimal or non-invasive surgical treatment and hold the largest market share due to early adoption. Use of biophotonics for early diagnosis of the diseases such as cancer and others has also helped to capture major market globally. North America region is the largest in terms of market share while the Asia Pacific is expected to grow at the fastest rate during the next five years. This is due to growing cases of chronic diseases coupled with rising aging as well as the geriatric population in the region. However, the growth of global biophotonics market will be restrained due to highly complex biophotonics technology coupled with the high price of biophotonics-based instruments during the forecast period.
Research Methodology
The report provides brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.
Market Dynamics
This section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of biophotonics. Complete industry analysis has also been covered through Porter’s five forces model as a part of this report section.
Segmentation
Global biophotonics market is segmented on the basis of end-user, application, technology, and geography.
By End User
Medical
Diagnostics
Therapeutics
Test Component
Non-Medical
By Application
See-through
Inside Imaging
Surface Imaging
Microscopy
Light Therapy
Biosensor
Others
By Technology
In-Vivo
In-Vitro
By Geography
North America
US
Canada
Mexico
Others
South America
Brazil
Others
Europe
United Kingdom
Germany
France
Italy
Spain
Others
Middle East and Africa
Asia Pacific
Japan
China
India
Australia
Others
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Porter’s 5 Forces Analysis
4.6. Industry Regulations
4.7. Technology Overview
4.8. Industry Value Chain Analysis
5. BIOPHOTONICS MARKET FORECAST BY END USER (US$ BILLION)
5.1. Medical
5.1.1. Diagnostics
5.1.2. Therapeutics
5.1.3. Test Component
5.2. Non-Medical
6. BIOPHOTONICS MARKET FORECAST BY APPLICATION (US$ BILLION)
6.1. See-through
6.2. Inside Imaging
6.3. Surface Imaging
6.4. Microscopy
6.5. Light Therapy
6.6. Biosensor
6.7. Others
7. BIOPHOTONICS MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
7.1. In-Vivo
7.2. In-Vitro
8. BIOPHOTONICS MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Others
8.3. Europe
8.3.1. United Kingdom
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Others
8.4. Middle East and Africa
8.5. Asia Pacific
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Investment Analysis
9.2. Recent Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Affymetrix Inc.
10.2. Becton, Dickinson and Company
10.3. Carl Zeiss Microimaging GmbH
10.4. FEI Company
10.5. Hamamatsu Photonics K.K.
10.6. Newport Corporation
10.7. Ocean Optics
10.8. PerkinElmer Inc.
10.9. Andor Technology
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Segmentation
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Porter’s 5 Forces Analysis
4.6. Industry Regulations
4.7. Technology Overview
4.8. Industry Value Chain Analysis
5. BIOPHOTONICS MARKET FORECAST BY END USER (US$ BILLION)
5.1. Medical
5.1.1. Diagnostics
5.1.2. Therapeutics
5.1.3. Test Component
5.2. Non-Medical
6. BIOPHOTONICS MARKET FORECAST BY APPLICATION (US$ BILLION)
6.1. See-through
6.2. Inside Imaging
6.3. Surface Imaging
6.4. Microscopy
6.5. Light Therapy
6.6. Biosensor
6.7. Others
7. BIOPHOTONICS MARKET FORECAST BY TECHNOLOGY (US$ BILLION)
7.1. In-Vivo
7.2. In-Vitro
8. BIOPHOTONICS MARKET FORECAST BY GEOGRAPHY (US$ BILLION)
8.1. North America
8.1.1. US
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Others
8.3. Europe
8.3.1. United Kingdom
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Others
8.4. Middle East and Africa
8.5. Asia Pacific
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Investment Analysis
9.2. Recent Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. Affymetrix Inc.
10.2. Becton, Dickinson and Company
10.3. Carl Zeiss Microimaging GmbH
10.4. FEI Company
10.5. Hamamatsu Photonics K.K.
10.6. Newport Corporation
10.7. Ocean Optics
10.8. PerkinElmer Inc.
10.9. Andor Technology
